sickle cell anemia - Nursing Case Study
Pathophysiology
• Primary mechanism: Sickle cell anemia arises from a genetic mutation in the beta-globin gene, leading to the production of hemoglobin S (HbS). Under low oxygen conditions, HbS polymerizes, causing red blood cells to assume a rigid, sickle shape.
• Secondary mechanism: The sickled red blood cells have decreased deformability, leading to vaso-occlusion in microcirculation. This causes ischemia and reperfusion injury, exacerbating tissue hypoxia and leading to pain crises.
• Key complication: Chronic hemolysis of sickled cells results in severe anemia and release of free hemoglobin, causing nitric oxide depletion and endothelial dysfunction, which further enhances vaso-occlusive episodes and risks of acute chest syndrome, stroke, and organ damage.
Patient Profile
Demographics:
29-year-old female, research scientist
History:
• Key past medical history: Diagnosed with sickle cell anemia at age 2, history of multiple vaso-occlusive crises, acute chest syndrome, avascular necrosis in the left hip, and splenic sequestration
• Current medications: Hydroxyurea, folic acid, penicillin prophylaxis, pain management regimen including opioids
• Allergies: Allergic to penicillin
Current Presentation:
• Chief complaint: Severe chest pain and difficulty breathing
• Key symptoms: Intense joint pain, fatigue, fever, shortness of breath, and jaundice
• Vital signs: Temperature 102.4°F, heart rate 130 bpm, respiratory rate 28 breaths per minute, blood pressure 85/60 mmHg, oxygen saturation 88% on room air
Section 1
New Diagnostic Results:
Following the initial assessment, the multidisciplinary team prioritized rapid diagnostic investigations to clarify the extent of the patient's condition. A complete blood count revealed marked anemia with a hemoglobin level of 6.2 g/dL and reticulocytosis, indicating increased red blood cell turnover. The white blood cell count was elevated at 18,000 cells/µL, suggestive of a possible infectious process or inflammatory response. Blood chemistry showed elevated lactate dehydrogenase (LDH) at 600 U/L and increased indirect bilirubin, consistent with hemolysis. Arterial blood gases indicated a pH of 7.32, pCO2 of 30 mmHg, and HCO3- of 18 mEq/L, pointing towards a compensated metabolic acidosis, likely secondary to hypoxia and tissue ischemia.
Given the patient's severe chest pain and respiratory distress, a chest X-ray was performed, revealing bilateral infiltrates consistent with acute chest syndrome, a severe complication of sickle cell disease. A CT scan of the chest further confirmed diffuse pulmonary infiltrates and signs of pulmonary hypertension, a concerning development that could escalate her respiratory failure. The echocardiogram showed evidence of right ventricular strain, possibly due to increased pulmonary pressures. Blood cultures were drawn to rule out concurrent infection, given the patient's fever and elevated white cell count, while broad-spectrum antibiotics were initiated empirically due to her penicillin allergy.
These diagnostic results underscore the complexity of her clinical picture, challenging the team to balance aggressive management of acute chest syndrome while addressing potential infectious etiologies and ensuring adequate oxygenation. The findings necessitate a reevaluation of her treatment plan, including consideration for exchange transfusion to reduce sickle cell burden, alongside supportive measures such as supplemental oxygen, analgesia optimization, and careful fluid management. The team must also remain vigilant for further complications such as multi-organ dysfunction, requiring coordinated critical care interventions.
Section 2
Change in Patient Status:
As the clinical team continued to monitor the patient's condition, a rapid change in her status prompted immediate intervention. Over the course of several hours, the patient's respiratory distress escalated, with her oxygen saturation dropping to 84% despite high-flow supplemental oxygen. Her respiratory rate increased to 36 breaths per minute, and she exhibited pronounced use of accessory muscles. Auscultation revealed diminished breath sounds with crackles, particularly in the lower lobes, suggesting worsening acute chest syndrome and potential alveolar collapse. Her heart rate surged to 130 beats per minute, while blood pressure remained stable at 110/70 mmHg.
In parallel with her respiratory deterioration, the patient developed new neurological symptoms. She became increasingly lethargic and was intermittently unresponsive to verbal stimuli. The Glasgow Coma Scale score dropped to 12, indicating a concerning decline in her neurological status. Repeat laboratory investigations were ordered, revealing a further drop in hemoglobin to 5.8 g/dL and a rising lactate level of 4.5 mmol/L, suggesting tissue hypoperfusion and possible impending shock. The team recognized the critical nature of the situation, hypothesizing that the acute chest syndrome might have precipitated cerebral hypoxia or an acute cerebrovascular accident.
Given the severity of the patient's status, the team convened to reassess her management plan urgently. They decided to proceed with an exchange transfusion to rapidly reduce the sickle cell burden and improve oxygen-carrying capacity, aiming to stabilize her deteriorating respiratory and neurological condition. Simultaneously, a decision was made to intubate the patient to secure her airway and optimize ventilation, preventing further respiratory compromise. The critical care team prepared for potential neurological imaging to rule out acute cerebrovascular events and continued to manage her condition intensively while anticipating the need for further interventions to address multi-organ involvement.
Section 3
As the critical care team proceeded with the exchange transfusion and intubation, they observed an initial stabilizing effect on the patient's respiratory parameters. Her oxygen saturation improved to 92% with mechanical ventilation, and her respiratory rate decreased to 24 breaths per minute. However, despite these improvements, her neurological status remained concerning. A CT scan of the brain was performed, which revealed an acute ischemic stroke in the right middle cerebral artery territory. This finding confirmed the suspicion that the acute chest syndrome had led to cerebral hypoxia and subsequent cerebrovascular compromise.
In conjunction with the cerebral event, new laboratory results indicated worsening renal function, with serum creatinine levels rising to 2.3 mg/dL from a baseline of 1.0 mg/dL. Urinalysis showed proteinuria and microscopic hematuria, suggesting acute kidney injury possibly secondary to the sickle cell crisis and hypoperfusion. The patient's lactate level, although slightly reduced, remained elevated at 3.8 mmol/L, still indicating ongoing tissue hypoxia and metabolic stress.
Recognizing the multi-organ involvement, the clinical team expanded their management strategy to include renal support. They initiated continuous renal replacement therapy (CRRT) to manage the acute kidney injury and prevent fluid overload, considering her risk for further complications. The team also consulted with neurology to implement appropriate stroke management protocols, balancing the need for anticoagulation with the risks of bleeding in the context of her recent exchange transfusion. The patient's complex and evolving clinical picture required ongoing critical assessment and swift adaptation of the management plan to address the interplay between respiratory, neurological, and renal complications, setting the stage for intensive multidisciplinary care.
Section 4
As the critical care team continued to monitor the patient, they noted a sudden change in her neurological status. The patient, previously responsive to verbal stimuli, became unresponsive to even painful stimuli. Her pupils were unequal, with the right pupil dilated and sluggish to light, suggesting increased intracranial pressure or further ischemic insult. The team immediately performed a repeat CT scan, which showed new signs of cerebral edema and possible hemorrhagic transformation at the site of the initial infarct. This alarming change prompted an urgent discussion regarding the need for neurosurgical intervention or further medical management to control the intracranial pressure.
Concurrently, the patient's cardiovascular status began to deteriorate. Her blood pressure dropped to 85/50 mmHg, and her heart rate increased to 130 beats per minute, indicating hemodynamic instability likely due to a combination of fluid shifts, ongoing anemia, and possible sepsis. Blood cultures were drawn, and broad-spectrum antibiotics were initiated preemptively. Meanwhile, the CRRT was adjusted to optimize fluid balance and support blood pressure, alongside administration of vasoactive medications to maintain adequate perfusion.
The team faced the challenge of balancing aggressive management of her acute stroke symptoms with the need to stabilize her cardiovascular system. A multidisciplinary approach was employed, involving critical care, neurology, nephrology, and infectious disease specialists to reassess and refine the treatment plan. This scenario underscored the complexity of managing sickle cell crises with multi-organ involvement, requiring advanced critical thinking and swift, coordinated action to navigate the evolving clinical landscape. The team prepared for potential escalation of care, including discussions about the need for surgical decompression or more invasive monitoring techniques, while closely monitoring the patient's response to the current interventions.
Section 5
As the critical care team implemented the revised management strategy, they closely monitored the patient's response to the interventions. Over the next several hours, the patient's neurological status remained concerning. Despite the administration of hyperosmolar therapy to reduce cerebral edema, her pupils showed no improvement, and she remained unresponsive. Her Glasgow Coma Scale score remained at 5, with no eye-opening, no verbal response, and only withdrawal to painful stimuli. This lack of neurological improvement, coupled with the CT scan findings, prompted the team to consult with neurosurgery to evaluate the potential benefits versus risks of surgical decompression.
Concurrently, the patient's cardiovascular status continued to be precarious. Despite fluid resuscitation and vasopressor support, her blood pressure remained labile, fluctuating between 80/45 mmHg and 95/60 mmHg. Laboratory results indicated worsening anemia, with hemoglobin levels dropping to 6.8 g/dL, likely exacerbated by hemolysis and sequestration crises. Additionally, lactate levels had risen to 4.5 mmol/L, suggesting inadequate tissue perfusion and potential progression towards septic shock. Repeat blood cultures identified the presence of Klebsiella pneumoniae, necessitating a modification in antibiotic therapy to target this pathogen specifically.
This multifaceted clinical picture required the team to continuously reassess and adapt their approach, integrating insights from all specialties involved. The critical care team prioritized maintaining cerebral perfusion pressure while managing the underlying infection and anemia, all while preparing for potential surgical intervention. This case underscored the necessity for precise clinical judgment, as the team balanced the competing priorities of managing neurological and cardiovascular deterioration amidst the backdrop of a sickle cell crisis. The next steps involved monitoring the patient's response to the revised antibiotic regimen and exploring advanced supportive measures, including transfusion strategies and potential surgical options, to stabilize her condition.